A 7-year delayed diagnosis in a case of spinal muscular atrophy

IF 1.3 4区 医学 Q4 CLINICAL NEUROLOGY Brain & Development Pub Date : 2025-04-01 Epub Date: 2025-01-23 DOI:10.1016/j.braindev.2025.104320
Hideyuki Iwayama , Tatsuya Fukasawa , Yoshiteru Azuma , Hirokazu Kurahashi , Yoshinori Ito , Akihisa Okumura
{"title":"A 7-year delayed diagnosis in a case of spinal muscular atrophy","authors":"Hideyuki Iwayama ,&nbsp;Tatsuya Fukasawa ,&nbsp;Yoshiteru Azuma ,&nbsp;Hirokazu Kurahashi ,&nbsp;Yoshinori Ito ,&nbsp;Akihisa Okumura","doi":"10.1016/j.braindev.2025.104320","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Most cases of spinal muscular atrophy (SMA) can be diagnosed by copy number analysis of survival motor neuron (<em>SMN</em>) 1. However, a small number of cases of SMA can only be diagnosed by sequencing analysis. We present a case of SMA diagnosed 7 years after the onset of symptoms.</div></div><div><h3>Case report</h3><div>She was a 12-year-old girl of Sri Lankan origin. At age 5, she began to fall easily. She had normal intellectual development, and electromyography suggested a neurogenic disorder. Copy number analysis of <em>SMN1</em> exons 7 and 8 via polymerase chain reaction revealed at least one copy of <em>SMN1</em>. Exome sequence analysis for neuromuscular disorders panel could not detect the pathogenic mutation. She moved to Japan at the age of 12 years. Sequencing analysis later identified a novel mutation in <em>SMN1</em> at the same locus as previously reported (c.284G&gt;A: p.Gly95Glu). Multiple ligation-dependent probe amplification indicated she had two copies of <em>SMN2</em>. She was diagnosed with SMA type 3b and treated with nusinersen.</div></div><div><h3>Discussion</h3><div>In patients with SMA, 2–5 % have a point mutation or a small insertion/deletion in <em>SMN1</em>. Since copy number analysis cannot detect such mutations, sequencing analysis is required. Two copies of <em>SMN2</em> often result in SMA type 1 or 2, but her mild symptoms of SMA type 3b may be due to a combination of a point mutation and a deletion in <em>SMN1</em>.</div></div><div><h3>Conclusion</h3><div>Even if genetic testing has been performed at previous institutions, sequencing analysis should be considered if the patient's symptoms are consistent with SMA.</div></div>","PeriodicalId":56137,"journal":{"name":"Brain & Development","volume":"47 2","pages":"Article 104320"},"PeriodicalIF":1.3000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Brain & Development","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0387760425000014","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/23 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Most cases of spinal muscular atrophy (SMA) can be diagnosed by copy number analysis of survival motor neuron (SMN) 1. However, a small number of cases of SMA can only be diagnosed by sequencing analysis. We present a case of SMA diagnosed 7 years after the onset of symptoms.

Case report

She was a 12-year-old girl of Sri Lankan origin. At age 5, she began to fall easily. She had normal intellectual development, and electromyography suggested a neurogenic disorder. Copy number analysis of SMN1 exons 7 and 8 via polymerase chain reaction revealed at least one copy of SMN1. Exome sequence analysis for neuromuscular disorders panel could not detect the pathogenic mutation. She moved to Japan at the age of 12 years. Sequencing analysis later identified a novel mutation in SMN1 at the same locus as previously reported (c.284G>A: p.Gly95Glu). Multiple ligation-dependent probe amplification indicated she had two copies of SMN2. She was diagnosed with SMA type 3b and treated with nusinersen.

Discussion

In patients with SMA, 2–5 % have a point mutation or a small insertion/deletion in SMN1. Since copy number analysis cannot detect such mutations, sequencing analysis is required. Two copies of SMN2 often result in SMA type 1 or 2, but her mild symptoms of SMA type 3b may be due to a combination of a point mutation and a deletion in SMN1.

Conclusion

Even if genetic testing has been performed at previous institutions, sequencing analysis should be considered if the patient's symptoms are consistent with SMA.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
延迟7年诊断脊髓性肌萎缩症1例。
背景:大多数脊髓性肌萎缩症(SMA)可通过存活运动神经元(SMN)拷贝数分析进行诊断。然而,少数SMA病例只能通过测序分析来诊断。我们提出一个病例的SMA诊断7年后出现的症状。病例报告:她是一名斯里兰卡裔12岁女孩。5岁时,她开始容易摔倒。她智力发育正常,肌电图显示为神经源性疾病。通过聚合酶链反应对SMN1外显子7和8的拷贝数进行分析,发现SMN1至少有一个拷贝。神经肌肉疾病组外显子组序列分析不能检测到致病突变。她在12岁时移居日本。测序分析随后在先前报道的相同位点(c.284G> a: p.Gly95Glu)发现了SMN1的新突变。多重连接依赖探针扩增显示她有两个SMN2拷贝。她被诊断为3b型SMA,并接受nusinersen治疗。讨论:在SMA患者中,2- 5%的SMN1有点突变或小的插入/缺失。由于拷贝数分析无法检测到这种突变,因此需要测序分析。SMN2的两个拷贝通常导致SMA 1型或2型,但她的SMA 3b型轻度症状可能是由于SMN1的点突变和缺失的结合。结论:即使在以前的机构进行过基因检测,如果患者的症状与SMA一致,也应考虑进行测序分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Brain & Development
Brain & Development 医学-临床神经学
CiteScore
3.60
自引率
0.00%
发文量
153
审稿时长
50 days
期刊介绍: Brain and Development (ISSN 0387-7604) is the Official Journal of the Japanese Society of Child Neurology, and is aimed to promote clinical child neurology and developmental neuroscience. The journal is devoted to publishing Review Articles, Full Length Original Papers, Case Reports and Letters to the Editor in the field of Child Neurology and related sciences. Proceedings of meetings, and professional announcements will be published at the Editor''s discretion. Letters concerning articles published in Brain and Development and other relevant issues are also welcome.
期刊最新文献
Post-stimulus rebound of EEG power in response to vocal and non-vocal sounds in children with and without autism spectrum disorder: An exploratory study Management of febrile seizures in Türkiye: A nationwide survey of pediatricians and pediatric neurologists Management of pediatric status epilepticus after hospital arrival in Japan: A nationwide questionnaire survey From a caregiver perspective: Quality of life of children with epilepsy and autism spectrum disorder – a single site case-control study Emerging disease-modifying therapies for Angelman syndrome: A comprehensive review for pediatric neurologists
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1